- AUGUST 7 2020
On Friday, August 7, 2020, Acutus Medical, Inc. (Nasdaq: AFIB) President and CEO, Vince Burgess rang the Nasdaq Opening Bell remotely from across the country alongside the Acutus team.
- MAY 29 2020
"Acutus Medical and Biotronik have announced that they will collaborate on electrophysiology, mapping, ablation and accessory products across certain markets."
- FEBRUARY 19 2020
"Acutus Medical Inc. is working to build itself into a major competitor in cardiac electrophysiology."
- JANUARY 24 2020
“AcQMap utilises precision ultrasound atrial anatomy imaging and high-definition non-contact charge mapping to visually represent real-time electrical patterns in the left and right atria during complex arrhythmias.”
- DECEMBER 26 2019
“Acutus Medical had an exciting year in 2019 and we expect 2020 to be no different for the company, which is building an entire EP product line around its AcQMap system. The technology is designed to enable imaging, visualization, planning, and ablation all in one system.”
- OCTOBER 09 2019
Acutus Medical and Innovative Health Collaborate to Increase Patient Access to Electrophysiology Care
“Companies will enter a partnership that offers hospitals Acutus technology together with regulated reprocessing of single-use devices”
- SEPTEMBER 11 2019
“2019 has been an exciting year for Acutus Medical, a company that Needham & Co. recently called out as an interesting private medical device company to watch.”
- JULY 15 2019
“Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The study demonstrated 73 percent single-procedure freedom from atrial fibrillation (AF) at 12 months with the use of Acutus' AcQMap advanced cardiac imaging and mapping system.”
- JUNE 21 2019
“Acutus Medical Inc. has raised $100 million of equity to support the commercial launch of technology designed to enable better treatment of atrial fibrillation and other common heart-rhythm disorders.”
- MAY 16 2019
“…Acutus’ approach combines focus on clinical efficacy and operational efficiency, something that is sorely needed in EP.”
- MARCH 28 2019
“New trial results show Acutus Medical's AcQMap platform has the ability to classify conduction patterns and localized non-pulmonary-vein therapeutic targets for ablation to treat atrial fibrillation, which could have implications for both treatment of atrial fibrillation and understanding the genetic markers for this common arrhythmia, according to the authors.”
- FEBRUARY 04 2019
“An atrial mapping catheter that combines ultrasound anatomic mapping with nontouch, high-resolution, charge-density mapping resulted in a high, 73% freedom from recurrent atrial fibrillation rate 12 months after ablation procedures guided by this catheter in a single-arm, multicenter study with 121 patients with persistent atrial fibrillation followed for 1 year.”
- MAY 14 2018
AcQMap Now Imaging Hearts with Ultrasound and Electricity in U.S.The [AcQMap] system’s novel catheter uses ultrasound and electrical tissue conduction mapping to provide a novel electrophysiologic live view inside the heart.
- JUNE 15 2016
“Securing $75m in venture capital is no mean feat in a tricky environment, but in March Acutus Medical pulled off the third largest medtech VC round of 2016 so far.”
All trademarks and copyrights are the property of their respective owners. By providing links to other sites, Acutus does not guarantee, approve, or endorse the information or products available on these sites.